About Us

about us

MULTILATERAL TRADING PTE LTD (MTPL)
MTPL was established in 1993 strategically in Singapore due to its business friendly environment and the access it gives to the South East Asian countries, which has been our focus to distribute and market Indian Pharmaceutical products in South East Asia

  • Vietnam was the first market we started our operations and a representative office was started in same year in Hanoi with a team of 3 people
  • In 1997 we established a second representative office in Ho Chi Minh City expanding our reach to the more active south Vietnam market
  • MTPL expanded its operations in Myanmar(In the Name of ESTIPHARMA LTD) in the year of 2015/16 and currently having a robust marketing team which is fast growing
  • Currently Product registrations are ongoing in Philipines, and most likely the marketing team will be in place by 2024
  • We have combined SKUs of 250+ products we market in the region



MAJOR ACHIEVEMENTS

  • First to launch Generic Esomeprazole, Daclatasvir  in Vietnam
  • Have been able to successfully  grew business by 300% in 3 years
  • Market Leadership in over 7 molecules
  • Any specific example of our efficient networking/relationship management which resulted in introducing a product to tender/quota/special import.
  • Estipharma is marketing 150 products in Myanmar.
  • MTPL is marketing 120 products in Vietnam

ESTI Pharma Pvt. Ltd. is the marketing company in Pharma sector founded by Mr. Subhash Ramakrishnappa, pharma businessman and technocrat by profession who has more than 20 years’ experience in the field of pharmaceutical formulations. Having started his career in Pharmaceutical Industry in Vietnam, he soon realized the importance of quality medicinal and Health care products for good health. This realization made him in setting up a Drugs, Food & Health supplement Marketing Company, Thus began his unending sojourn of developing quality healthcare products for human wellness. Combining his vast knowledge of formulation development with the in depth knowledge of Marketing, he has been the pioneer in developing our current range of products.

ESTI Pharma Pvt. Ltd. is one of the fast growing, professionally managed company, having interests in Human Health Services. It was incorporated in the year 2016 with a very broad and noble vision of providing people Good Health. The operation was successfully initiated in the Myanmar market. The company currently has its own marketing field staff throughout the country. The Company has two registered offices, one at Yangon and the other at Mandalay.

ESTI Pharma is poised to expand manifold by expanding operations in other ASEAN countries with registered products. It has already registered products in Cambodia, Vietnam, Philippines, Hong Kong, Indonesia and Malaysia.

FUTURE VISION
ESTI Pharma Pvt. Ltd is contemplating a major foray in the field of Life Saving Drugs such as Cancer, Aids, Fulminant Viral Hepatitis, Paralysis / Paraplegia, Alzheimer’s Disease / Irreversible Organic Degenerative Brain Disorders etc.
The Team is being managed under the competent leadership of its Marketing Director and CEO Mr Subhash Ramakrishnappa and in this field of healthcare products since last 20 years.

CORE PHILOSOPHY
“Every organization is based on a core philosophy which governs its functioning. Our core philosophy is Excellence, Success Through Integrity. ESTI Pharma ensures the availability and affordability of efficacious, safe and good quality medicines relevant to the health care needs of the people in a sustainable and equitable manner “.

Our Strength

esti strength

Timeline

Inception of MTPL

Started Ha Noi Representative Office

Started Ho Chi Minh City Representative Office

Launched products of major Generic Manufacturers from India

Representation and Marketing of Hetero Drugs Ltd

Reached the peak of Registered and Marketed SKUs of 190

Reached First Generic brand status for Telmisartan and Esomeprazole

Reached within Top 3 Generic brand status for 2more products, Pregabalin and Valsartan

Focus on building robust regulatory team with expertise in ACTD dossiers

One of the Earliest Brand to launch Sofosbuvir, Daclatasvir and Sofosbuvir + Daclatasvir

Expansion to Myanmar

Focus on EU Vendor Development

First EU vendor product filed, 5 more Licencing agreements signed

1993
1997
2007
2008
2012
2013
2015
2017